Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BENSERAZIDE\LEVODOPA Cause Psychomotor hyperactivity? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Psychomotor hyperactivity have been filed in association with BENSERAZIDE\LEVODOPA. This represents 0.9% of all adverse event reports for BENSERAZIDE\LEVODOPA.

18
Reports of Psychomotor hyperactivity with BENSERAZIDE\LEVODOPA
0.9%
of all BENSERAZIDE\LEVODOPA reports
1
Deaths
18
Hospitalizations

How Dangerous Is Psychomotor hyperactivity From BENSERAZIDE\LEVODOPA?

Of the 18 reports, 1 (5.6%) resulted in death, 18 (100.0%) required hospitalization.

Is Psychomotor hyperactivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BENSERAZIDE\LEVODOPA. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does BENSERAZIDE\LEVODOPA Cause?

Fall (282) Dizziness (151) Hallucination (136) Dyskinesia (127) General physical health deterioration (127) Parkinson's disease (126) Drug ineffective (119) Confusional state (117) Off label use (112) Somnolence (110)

What Other Drugs Cause Psychomotor hyperactivity?

METHYLPHENIDATE (617) QUETIAPINE (412) ARIPIPRAZOLE (389) OLANZAPINE (366) SERTRALINE (288) MONTELUKAST (282) RISPERIDONE (277) LEVETIRACETAM (247) VENLAFAXINE (214) LEVOTHYROXINE (211)

Which BENSERAZIDE\LEVODOPA Alternatives Have Lower Psychomotor hyperactivity Risk?

BENSERAZIDE\LEVODOPA vs BENZALKONIUM BENSERAZIDE\LEVODOPA vs BENZOCAINE BENSERAZIDE\LEVODOPA vs BENZODIAZEPINE BENSERAZIDE\LEVODOPA vs BENZONATATE BENSERAZIDE\LEVODOPA vs BENZOYL PEROXIDE

Related Pages

BENSERAZIDE\LEVODOPA Full Profile All Psychomotor hyperactivity Reports All Drugs Causing Psychomotor hyperactivity BENSERAZIDE\LEVODOPA Demographics